medigraphic.com
ISSN 1561-3070 (Electronic)

2019, Number 2

<< Back

Rev Cub Oftal 2019; 32 (2)

Acanthamoeba parasitic eye infection

Benítez MMC, Núñez FFA, Pérez PZ, Noriega MJL, Castillo PAC

Language: Spanish
References: 35
Page: 1-15
PDF size: 370.11 Kb.


ABSTRACT

Parasitism is one of the most surprising phenomena among those occurring in animals. The number of known parasitic organisms is very high. There is a large number of species whose survival is related to that of others and depend on them to a greater or lesser degree. Such dependence does not imply that parasitic animals are either degenerate or deficient. On the contrary, parasitic life has been the result of a long process of evolution along which parasites have gradually overcome hurdles and have adapted to live in or on their hosts. Acanthamoeba keratitis is a rare disease, but a worldwide increase has been reported due to the growing use of contact lenses. Early diagnosis and appropriate treatment are required to prevent sight loss. A search was conducted for published papers with the purpose of learning about Acanthamoeba as a parasite and the related eye conditions. Use was made of the platform Infomed, specifically the Virtual Health Library.


REFERENCES

  1. Gómez Marín JE. Protozoología Médica. Bogotá: Manual Moderno; 2010. p. 173-83.

  2. Sarría Pérez CA. Amebas de vida libre. En: Llop A, Valdés-Dapena M, Zuazo JL, editores. Microbiología y Parasitología Médicas. Tomo III. Capítulo 85. Ciudad de La Habana: Editorial Ciencias Médicas; 2001. p. 125-30.

  3. Kanski JJ. Oftalmología Clínica. Editorial Harcourt; 2000;4:93-4.

  4. Stehr-Green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107:331-6.

  5. Dart JK, Saw VP, Kilvington S. Acanthamoeba keratitis: diagnosis and treatment update. Am J Ophthalmol. 2009;148:487-99.

  6. Vivesvara GS. Pathogenic and opportunistic free-living amebae. En: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editores. Manual of Clinical Microbiology. Washington, DC: ASM Press; 1995;1195-203.

  7. John KJ, Head WS, Robinson RD, Williams TE, O’Day DM. Examination of the contact lens light microscopy: an aid in diagnosis of Acanthamoeba keratitis. Rev Infect Dis. 1991;13:S425.

  8. Radford CF, Minassian DC, Dart JKG. Disposable contact lens use as a risk factor for microbial keratitis. Br J Ophthalmol. 1998;82:1272-5.

  9. Pfister DR, Cameron JD, Krachmer JH, Holland EJ. Confocal microscopy findings of Acanthamoeba keratitis. Am J Ophthalmol. 1996;121:119-28.

  10. Gertiser ML, Giagante E, Sgattoni E, Basabe N, Rivero F, Luján H, et al. Queratitis por Acanthamoeba sp.: primer caso confirmado por aislamiento y tipificación molecular en Bahía Blanca, provincia de Buenos Aires, Argentina. Rev Argent Microbiol. 2010;42:122-5.

  11. Ledee DR, Hay J, Byers TJ, Seal DV, Kirkness CM. Acanthamoeba griffini. Molecular characterization of a new corneal pathogen. Invest Ophthalmol Vis Sci. 1996;37:544-50.

  12. Claerhout I, Goegebuer A, Van Den Broecke C, Kestelyn P. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol. 2004;242:648-53.

  13. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol. 2006;17:327-31.

  14. Pasricha G, Sharma S, Garg P, Aggarwal RK. Use of 18S rRNA gene-based PCR assay for diagnosis of Acanthamoeba keratitis in non-contact lens wearers in India. J Clin Microbiol. 2003;41:3206-11.

  15. Petri WA, Ravdin JL. Free-living amebae. En: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious disease. NY: Churchil Livingstone Inc.; 1997;2049-56.

  16. Chew SJ, Beuerman RW, Assouline M, Kaufman HE, Barron BA, Hill JM. Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J. 1992;18:197-201.

  17. Mastropasqua L, Nubile M. Normal Corneal Morphology. En: Confocal Microscopy of the cornea. Italy: University G. D’Annungio. Slack Incorporating; 2002:7-14.

  18. Baudouin C, Bourcier T, Dupas B, Labbé A, Sonigo B. Principes techniques de la microscopie confocale. Les Cahiers dophtalmologie. 2007;110:16.

  19. Shiraishi A, Uno T, Oka N, Hara Y, Yamaguchi M, Ohashi Y. In vivo and in vitro laser confocal microscopy to diagnose Acanthamoeba keratitis. Cornea. 2010;29:861-5.

  20. Vaddavalli PK, Garg P, Sharma S, Sangwan VS, Rao GN, Thomas R. Role of confocal microscopy in the diagnosis of fungal and Acanthamoeba keratitis. Ophthalmology. 2001;118:29-35.

  21. Lim N, Goh D, Bunce C, Xing W, Fraenkel G, Poole TR, Ficker L. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol. 2008;145:130-5.

  22. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with topical polyhexamethyl biguanide. Ophthalmology. 1992;99:185-91.

  23. Sharma S, Garg P, Rao GN. Patient characteristics, diagnosis and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol. 2000;84:1103-8.

  24. Qian Y, Meisler DM, Langston RH, Jeng BH. Clinical experience with Acanthamoeba keratitis at the Cole eye institute, 1999–2008. Cornea. 2010;29:1016-21.

  25. Mutoh T, Ishikawa I, Matsumoto Y, Chikuda M. A retrospective study of nine cases of Acanthamoeba keratitis. Clin Ophthalmol. 2010;4:1189-92.

  26. Kashiwabuchi RT, de Freitas D, Alvarenga LS, Vieira L, Contarini P, Sato E, et al. Corneal graft survival after therapeutic keratoplasty for Acanthamoeba keratitis. Acta Ophthalmol. 2008;86:666-9.

  27. Kitzmann AS, Goins KM, Sutphin JE, Wagoner MD. Keratoplasty for treatment of Acanthamoeba keratitis. Ophthalmology. 2009;116:864-9.

  28. Khan YA, Kashiwabuchi RT, Martins SA, Castro-Combs JM, Kalyani S, Stanley P, et al. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive Acanthamoeba keratitis: report of 3 cases. Ophthalmology. 2011;118:324-31.

  29. Espinosa Barberi, Miranda Fernández, Tandón Cárdenes. Nuevos tratamientos para la queratitis por Acanthamoeba: revisión de casos clínicos. Arch. Soc. Canar. Oftal. 2017;28:110-5.

  30. Martín-Navarro Carmen M. López-Arencibia Atteneri, Sifaoui Ines. Statins and voriconazol induce programmed cell death in Acanthamoeba castellanii. Antimicrob Agents Chemoter. 2015;59:2817-24.

  31. Lorenzo-Morales J, Khan Naveed A, Walochnik J. An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment. Parasite. 2015;22:10.

  32. Martín-Navarro CM, López Arencibia A, Arnalich-Montiel F. Evaluation of the in vitro activity of commercially available moxiflocin and voriconazol eye-drops against clinical strains of Acanthamoeba. Arch Clin Exp Ophtalmol. 2013;251:2111-7.

  33. Shi W, Liu M, Gao H, Li S, Xie L. Perioperative treatment and prognostic factors for penetrating keratoplasty in Acanthamoeba keratitis unresponsive to medical treatment. Graefes Arch Clin Exp Ophthalmol. 2009;247:1383-8.

  34. Kandori M, Inoue T, Shimabukuro M, Hayashi H, Hori Y, Maeda N, et al. Four cases of Acanthamoeba keratitis treated with phototherapeutic keratectomy. Cornea. 2010;29:1199-1202.

  35. Gopinathan U, Sharma S, Garg P, Rao GN. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade. Indian J Ophthalmol. 2009;57:273-9.




2020     |     www.medigraphic.com